Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley C Jordan

Showing results (131-140 of 191) with videos related to

Pageof 20
Sort By:
Pediatric Transplantation|August 21, 2021
Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case seriesDechu P Puliyanda, Stanley C Jordan, Irene K Kim, et al.
Transplantation Direct|September 21, 2018
Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant RecipientsStanley C Jordan, Suphamai Bunnapradist, Jonathan S Bromberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplantation|May 31, 2017
Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated RejectionHao Zhang, Edmund Huang, Joseph Kahwaji, et al.
Clinical Science (London, England : 1979)|October 7, 2016
Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in interleukin-13-induced minimal change-like nephropathyChang-Yien Chan, Kar-Hui Ng, Jinmiao Chen, et al.
Journal of the American Society of Nephrology : JASN|April 13, 2007
Overexpression of interleukin-13 induces minimal-change-like nephropathy in ratsKin-Wai Lai, Chang-Li Wei, Li-Kiang Tan, et al.
Transplantation|January 22, 2015
A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patientsAshley A Vo, Adriana Zeevi, Jua Choi, et al.
Transplantation|March 19, 2019
Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney TransplantationAshley A Vo, Olivier Aubert, Mark Haas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Transplantation Direct|June 5, 2026
CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized PatientsStanley C Jordan, Sindhu Chandran, Noriko Ammerman, et al.
Pageof 20

Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Pediatric Transplantation|August 21, 2021
Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case seriesDechu P Puliyanda, Stanley C Jordan, Irene K Kim, et al.
Transplantation Direct|September 21, 2018
Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant RecipientsStanley C Jordan, Suphamai Bunnapradist, Jonathan S Bromberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplantation|May 31, 2017
Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated RejectionHao Zhang, Edmund Huang, Joseph Kahwaji, et al.
Clinical Science (London, England : 1979)|October 7, 2016
Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in interleukin-13-induced minimal change-like nephropathyChang-Yien Chan, Kar-Hui Ng, Jinmiao Chen, et al.
Journal of the American Society of Nephrology : JASN|April 13, 2007
Overexpression of interleukin-13 induces minimal-change-like nephropathy in ratsKin-Wai Lai, Chang-Li Wei, Li-Kiang Tan, et al.
Transplantation|January 22, 2015
A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patientsAshley A Vo, Adriana Zeevi, Jua Choi, et al.
Transplantation|March 19, 2019
Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney TransplantationAshley A Vo, Olivier Aubert, Mark Haas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Transplantation Direct|June 5, 2026
CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized PatientsStanley C Jordan, Sindhu Chandran, Noriko Ammerman, et al.
Pageof 20